|
|
||
|
|
Title: Synthetic HIV-2 gag and env oligopeptides reactive with HIV-2 specific antibodies United States Patent: 6,322,964 Inventors: Cosand; Wesley L. (Bothell, WA); Watson; Andrew J. (Seattle, WA); Houghton; Raymond L. (Kirkland, WA); Montagnier; Luc (LePlessy-Robinson, FR); Alizon; Marc (Paris, FR); Chamaret; Solange (Paris, FR)Assignee: Genetic Systems Corporation (Seattle, WA); Institut Pasteur (Paris, FR) Appl. No.: 268388Filed: June 30, 1994 Peptide sequences are disclosed which immunologically mimic proteins encoded by the env and gag regions of LAV-2, a retrovirus associated with AIDS. The peptide can be used in various specific binding assays to detect the presence of antibodies to LAV-2 in individuals previously exposed to the virus. The peptides enable one to distinguish the presence of antibodies to LAV-2 from antibodies to HIV-1. SUMMARY OF THE INVENTION
Peptide sequences capable of immunologically mimicking proteins encoded in
the env and gag regions of the LAV-2 retrovirus are provided as reagents
for use in the screening of blood and blood products for prior exposure to
the retrovirus. The peptides are at least five amino acids in length and
can be used in various specific binding assays for the detection of
antibodies to LAV-2 virus, for the detection of LAV-2 antigens, or as
immunogens. Peptides described in the examples enable one to distinguish
the presence of antibodies in a body fluid to LAV-2 from antibodies to
HIV-1. Claim 1 of 12 Claims
What is claimed is: ____________________________________________
|
|
|